Showing results (691-700 of 1,190) with videos related to
Sort By:
Pageof 119
BMC Pharmacology & Toxicology|April 25, 2020
In vitro and in vivo effects of flubendiamide and copper on cyto-genotoxicity, oxidative stress and spleen histology of rats and its modulation by resveratrol, catechin, curcumin and α-tocopherolRajesh Mandil, Atul Prakash, Anu Rahal, et al.BMC Pharmacology & Toxicology|April 9, 2020
Determination of parecoxib and valdecoxib in rat plasma by UPLC-MS/MS and its application to pharmacokinetics studiesMengchun Chen, Wei Sun, Zhe Wang, et al.BMC Pharmacology & Toxicology|June 25, 2020
Natural dietary compound naringin inhibits glioblastoma cancer neoangiogenesisSonia Aroui, Hamadi Fetoui, Abderraouf KenaniBMC Pharmacology & Toxicology|June 25, 2020
A randomized single-dose, two-period crossover bioequivalence study of two fixed-dose Paracetamol/Orphenadrine combination preparations in healthy volunteers under fasted conditionKit Yee Cheah, Kar Yee Mah, Lai Hui Pang, et al.BMC Pharmacology & Toxicology|May 2, 2021
The effective interplay of (non-) selective NSAIDs with neostigmine in animal models of analgesia and inflammationMennatallah A Gowayed, Amany Abdel-Bary, Rasha A El-TahanBMC Pharmacology & Toxicology|July 6, 2022
Bioequivalence evaluation and food effect assessment of Lisinopril/amlodipine tablets in healthy Chinese subjects under fasting and fed conditionsTing Li, Yan-Ping Liu, Shu-Qin Liu, et al.BMC Pharmacology & Toxicology|January 8, 2021
Comparative associations between anticholinergic burden and emergency department visits for anticholinergic adverse events in older Korean adults: a nested case-control study using national claims data for validation of a novel country-specific scaleSunghee Hwang, Jee Eun Chung, Kwanghee Jun, et al.BMC Pharmacology & Toxicology|January 8, 2021
N-acetylcysteine dose-dependently improves the analgesic effect of acetaminophen on the rat hot plate testSamaneh Nakhaee, Mohammad Dastjerdi, Hesam Roumi, et al.BMC Pharmacology & Toxicology|June 14, 2021
Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metforminRobert Dobbins, Elizabeth K Hussey, Robin O'Connor-Semmes, et al.BMC Pharmacology & Toxicology|June 17, 2021
In-silico evaluation of Malawi essential medicines and reactive metabolites for potential drug-induced toxicitiesIbrahim Chikowe, Alfred Chipanda Phiri, Kirios Patrick Mbewe, et al.Pageof 119